Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Photogen initiates development of ocular disease Rx; receives U.S. patents for technology

Dec. 7, 1998

Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis

Nov. 27, 1998

CytoTherapeutics receives patent protection for ocular delivery of therapeutic substances

Nov. 25, 1998

First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way

Nov. 24, 1998

Akorn announces U.S. market introduction for BioLon

Nov. 24, 1998

Latanoprost monotherapy is as effective as combination therapy in lowering IOP

Nov. 20, 1998

Three major studies support antiglaucoma efficacy of Cosopt

Nov. 19, 1998

Animal data suggest that GPI-1046 may be useful in glaucoma

Nov. 18, 1998

New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass

Nov. 16, 1998

Final results presented from phase II Vitrase trial

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...